* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Product Introduction
Pyrene-PEG2-azide is a pyrene labeled PEG linker containing an azide group, which enables Click Chemistry labeling with any alkyne-bearing molecules and thus turns any molecule into pyrene-bearing probe. The hydrophilic PEG linker can increase solubility and facilitate attachment to biomolecules in aqueous solutions.
Chemical Information
Product Specification
Computed Properties
Patents
Synonyms |
1-Pyrenecarboxylic acid-PEG2-azide; Pyrene azide 1; N-{2-[2-(2-azidoethoxy)ethoxy]ethyl}pyrene-1-carboxamide |
Purity |
96% |
IUPAC Name |
N-[2-[2-(2-azidoethoxy)ethoxy]ethyl]pyrene-1-carboxamide |
Canonical SMILES |
C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)C(=O)NCCOCCOCCN=[N+]=[N-] |
InChI |
InChI=1S/C23H22N4O3/c24-27-26-11-13-30-15-14-29-12-10-25-23(28)20-9-7-18-5-4-16-2-1-3-17-6-8-19(20)22(18)21(16)17/h1-9H,10-15H2,(H,25,28) |
InChIKey |
CXNRBKHYGKLDHH-UHFFFAOYSA-N |
Solubility |
DMSO, DMF, DCM |
Fluorescence Quantum Yield |
1.00 |
Excitation |
343; 326; 313 |
Emission |
377; 397 |
Storage |
-20 °C |
XLogP3 |
4.9 |
Hydrogen Bond Donor Count |
1 |
Hydrogen Bond Acceptor Count |
5 |
Rotatable Bond Count |
10 |
Exact Mass |
402.16919058 g/mol |
Monoisotopic Mass |
402.16919058 g/mol |
Topological Polar Surface Area |
61.9Ų |
Heavy Atom Count |
30 |
Formal Charge |
0 |
Complexity |
624 |
Isotope Atom Count |
0 |
Defined Atom Stereocenter Count |
0 |
Undefined Atom Stereocenter Count |
0 |
Defined Bond Stereocenter Count |
0 |
Undefined Bond Stereocenter Count |
0 |
Covalently-Bonded Unit Count |
1 |
Compound Is Canonicalized |
Yes |
Publication Number |
Title |
Priority Date |
US-2021292804-A1 |
Recombinant flavin-adenine dinucleotide glucose dehydrogenase and uses thereof |
2017-08-02 |
EP-3399967-A2 |
Selective killing of tumors of the hematopoietic and lymphoid tissues |
2016-01-05 |
US-2019022032-A1 |
Selective killing of tumors of the hematopoietic and lymphoid tissues |
2016-01-05 |
WO-2017120296-A2 |
Selective killing of tumors of the hematopoietic and lymphoid tissues |
2016-01-05 |
US-10905658-B2 |
Methods and compositions for detecting hematopoietic and lymphoid tissue cancer cells |
2016-01-05 |